<ol class="cite-this-references"><li id="reference-A187643">Shockcor JP, Wurm RM, Frick LW, Sanderson PN, Farrant RD, Sweatman BC, Lindon JC: Hplc-nmr identification of the human urinary metabolites of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analogue active against human immunodeficiency virus (HIV). Xenobiotica. 1996 Feb;26(2):189-99. doi: 10.3109/00498259609046699. [<a href="/articles/A187643" target="_blank">Article</a>] </li><li id="reference-A187673">Valade E, Treluyer JM, Bouazza N, Ghosn J, Foissac F, Benaboud S, Fauchet F, Viard JP, Urien S, Hirt D: Population pharmacokinetics of emtricitabine in HIV-1-infected adult patients. Antimicrob Agents Chemother. 2014;58(4):2256-61. doi: 10.1128/AAC.02058-13. Epub 2014 Feb 3. [<a href="/articles/A187673" target="_blank">Article</a>] </li><li id="reference-A187688">Orkin C, Llibre JM, Gallien S, Antinori A, Behrens G, Carr A: Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence. HIV Med. 2018 Jan;19(1):18-32. doi: 10.1111/hiv.12534. Epub 2017 Jul 24. [<a href="/articles/A187688" target="_blank">Article</a>] </li><li id="reference-A19948">Bocedi A, Notaril S, Narciso P, Bolli A, Fasano M, Ascenzi P: Binding of anti-HIV drugs to human serum albumin. IUBMB Life. 2004 Oct;56(10):609-14. [<a href="/articles/A19948" target="_blank">Article</a>] </li><li id="reference-L9010">FDA Press Announcements: FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic [<a href="https://www.fda.gov/news-events/press-announcements/fda-approves-second-drug-prevent-hiv-infection-part-ongoing-efforts-end-hiv-epidemic" target="_blank">Link</a>] </li><li id="reference-L9019">FDA Approved Drug Products: Emtriva (Emtricitabine) Oral Capsules [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021500s029lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L4388">FDA Approved Drug Products: Descovy (Emtricitabine and Tenofovir Alafenamide) Oral Tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208215s012lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L9818">Cayman Chemicals: Emtricitabine MSDS [<a href="https://www.caymanchem.com/msdss/16879m.pdf" target="_blank">Link</a>] </li><li id="reference-L9833">FDA Approved Drug Products: Truvada (emtricitabine and tenofovir disoproxil fumarate) tablets for oral use [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021752s061lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L9836">FDA Approved Drug Products: Symtuza (Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) Oral Tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210455s004lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L9587">FDA Approved Drug Products: Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets for oral use [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203100s036lblet.pdf" target="_blank">Link</a>] </li><li id="reference-L9839">FDA Approved Drug Products: Odefsey (Emtricitabine, Rilpivirine, and Tenofovir Alafenamide) [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208351s006lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L9647">FDA Approved Drug Products: Genvoya (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) Oral Tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207561s023lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L9842">FDA Approved Drug Products: Complera (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets for oral use [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202123s031lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L9845">FDA Approved Drug Products: Biktarvy (Bictegravir, Emtricitabine, and Tenofovir Alafenamide) Oral Tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210251s006lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L9848">FDA Approved Drug Products: Atripla (efavirenz, emtricitabine, and tenofovir disoproxil fumarate) tablets for oral use [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021937s044lbl.pdf" target="_blank">Link</a>] </li></ol>